"Phase I dose escalation and expansion trial of single agent ONC201 in " by Yazmin Odia, Doured Daghistani et al.

All Publications

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy

2022

Article

Additional authors and institutional affiliations

Neurooncol Adv (2022) 4(1):vdac143

This document is currently not available here.

COinS